FDA
-
FDA Reverses Course, Will Review Moderna’s mRNA Flu Vaccine
The U.S. Food and Drug Administration has reversed its initial refusal, agreeing to review Moderna’s mRNA flu vaccine application for the 2026/2027 flu season.
-
Recalled Genova Tuna Accidentally Shipped to 9 States, Posing Botulism Risk
Tri-Union Seafoods announced that previously recalled Genova Yellowfin Tuna products were inadvertently distributed to retailers in nine U.S. states, raising concerns about potential Clostridium botulinum contamination and urging consumers to discard or return the affected products.
-
FDA Recalls Spring Mulberry Chocolate Bars Over Salmonella Concerns, Urges Discarding
The FDA has announced a voluntary recall of Spring Mulberry’s Mint Leaf Date Sweetened Chocolate Bar due to potential salmonella contamination, urging consumers to discard the product and seek refunds. No illnesses have been reported.
-
Hidden Valley Ranch Recall: Plastic Contamination Prompts Action Across 27 States
Hidden Valley Ranch and several other Ventura Foods dressings have been recalled in 27 states after black plastic fragments were found in granulated onion ingredients, prompting swift action from retailers like Costco and FDA oversight.
-
Ventura Foods Salad Dressing Recall: Which Products Are Affected and What Consumers Should Do
Ventura Foods has recalled over 3,500 cases of salad dressing from major retailers due to contamination concerns. Here’s what’s been affected, where, and how consumers can respond.
-
Frozen Food Recalls in the US: Major Pizza and Salad Dressing Safety Alerts Shake Consumers in 2025
From metal fragments in organic pizza to plastic contamination in salad dressings, frozen food recalls have become a recurring concern for American consumers. This article examines the most significant recalls in recent years, the reasons behind them, and what these…
-
FDA Memo Reveals Child Deaths Linked to COVID Vaccine: What We Know and What’s Next
A confidential FDA memo has revealed at least 10 child deaths allegedly linked to COVID vaccination, sparking new scrutiny over vaccine safety and policy. Experts urge caution as details remain limited and broader context is debated.
-
Congress Sets 2025 Ban on THCA and Intoxicating Hemp: What the Year-Long Window Means for Businesses and Consumers
Congress has passed a measure banning most intoxicating hemp products, including THCA, with a 365-day transition period before enforcement. This sweeping change could reshape the market, legal landscape, and consumer access to hemp-derived products.
-
ByHeart Baby Formula Recall Widens: What Parents Need to Know Amid Botulism Outbreak
ByHeart has expanded its recall to include all baby formula products after over a dozen infants fell ill with botulism. Federal health agencies continue to investigate the outbreak, urging parents nationwide to discard all ByHeart formula and remain vigilant for…
-
FDA Lifts Black Box Warning: Menopause Hormone Therapy Reimagined for Millions
After two decades of strict warnings, the FDA has removed its black box label from menopause hormone therapy, opening the door for broader, safer access and a new era in women’s health.
-
ByHeart Infant Formula Recall: Botulism Cases Spur Nationwide Alert
A recall of ByHeart Whole Nutrition Infant Formula has been issued after 13 cases of infant botulism were linked to two specific lots across 10 U.S. states, prompting federal and state investigations and a nationwide safety warning.
-
Blood Pressure Medication Recall: What Patients Need to Know About Cancer-Causing Impurities
Nearly 590,000 bottles of prazosin hydrochloride have been recalled in the U.S. due to potentially cancer-causing nitrosamine impurities. Here’s a detailed look at the recall, the risks, and what patients should do next.
-
FDA Recall: Over 580,000 Bottles of Blood Pressure Medication Pulled for Cancer Risk
More than half a million bottles of prazosin hydrochloride, a common blood pressure medication, have been recalled nationwide due to unsafe levels of a potential cancer-causing impurity. The FDA classified the recall as Class II, urging patients to consult their…
-
Over 580,000 Bottles of Blood Pressure Medication Recalled Due to Cancer Risk: What Patients Need to Know
Teva Pharmaceuticals has voluntarily recalled over half a million bottles of prazosin hydrochloride blood pressure capsules after tests found unsafe levels of a cancer-linked impurity. Patients are urged to check their medication and consult their doctors for guidance.















